Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery

Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development ...
Reuters

Pfizer's gene therapy cuts hemophilia A bleeding rate in late-stage trial

July 24 (Reuters) - Pfizer's (PFE.N), opens new tab gene therapy for hemophilia A significantly cut the number of annual bleeding episodes in patients with the rare disorder in a late-stage study and ...
STAT

Pfizer’s Wall Street critic-turned-executive digs into the company’s problems, obesity plans

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Hosted on MSN

Pfizer's Q3 Non-Oncology Performance: Here's What to Expect

Pfizer PFE is due to report third-quarter 2025 results on Nov. 4. All eyes will be on sales of Pfizer’s oncology drugs, which account for more than 25% of the company’s total revenues. Pfizer’s key ...